Essity (ESSITY) 21st Annual dbAccess Global Consumer Conference 2024 summary
Event summary combining transcript, slides, and related documents.
21st Annual dbAccess Global Consumer Conference 2024 summary
31 Jan, 2026Business overview and strategic positioning
Operates in hygiene and health, reaching over 1 billion people daily across 150 countries, with 36,000 employees and 72 production facilities.
Holds leading market positions, being #1 or #2 in 90% of branded sales and #1 in 60% of branded sales across chosen segments, focusing on Health and Medical, Consumer Goods, and Professional Hygiene.
Recent divestment of Vinda reduced exposure to low-margin, capital-intensive consumer tissue, generating SEK ~19bn in proceeds and a capital gain of SEK ~9bn, and shifting the portfolio toward higher-margin, lower-volatility categories.
Achieved significant supply chain efficiencies and factory consolidation, enhancing operational effectiveness.
Maintains a strong sustainability agenda, recognized by major NGOs and integrated into product innovation.
Financial performance and targets
Over the past decade, achieved an 82% increase in sales and a 115% increase in EBITA, with an average annual sales increase of SEK 7.4bn and EBITA increase of SEK 1.1bn.
Q1 EBITDA margin at 14%, with Health and Medical at 19%, Consumer Goods at 13%, and Professional Hygiene over 15%.
Gross margin reached an all-time high of 33% in Q1, driven by mix changes and restructuring.
Net debt to EBITDA at 1.36, with strong cash flow and plans to update financial targets in Q2.
Return on capital employed at 17%, aided by the Vinda divestment, with ambitions to grow above 3% organically.
Growth drivers and market trends
Focused on aging populations, shifting investment from baby care to incontinence and healthcare.
Health and Medical benefits from sticky, long-term contracts and rapid pricing adjustments.
Professional Hygiene recovering post-COVID, with growth in hotels and industry but lower office demand.
Consumer Goods sees downtrading to private label in tissue, but brand loyalty remains strong in emotional categories.
Operating leverage and volume growth are key to future margin improvements.
Latest events from Essity
- Higher volumes and margins, strong cash flow, and SEK 3bn buyback offset sales decline.ESSITY
Q1 202623 Apr 2026 - Record profitability, higher dividend, and strategic US acquisition fuel growth and leadership.ESSITY
AGM 2026 presentation23 Apr 2026 - Profit margins and market shares rose in 2025, with acquisitions and cost-saving actions supporting growth.ESSITY
Q4 202520 Apr 2026 - Aiming for 3%+ organic growth and 15%+ margins, driven by innovation, brands, and efficiency.ESSITY
CMD 202417 Mar 2026 - Profitable growth is fueled by innovation, acquisitions, and strong global brand leadership.ESSITY
UBS Global Consumer and Retail Conference13 Mar 2026 - Targets raised: organic sales growth >3%, EBITA margin >15%, SEK 3bn buyback, focus on high-margin growth.ESSITY
Investor Update3 Feb 2026 - Record EBITA and margin gains, new growth targets, and a SEK 3bn buyback boost value.ESSITY
Q2 20243 Feb 2026 - Record cash flow, margin gains, and reduced net debt mark a robust Q3 2024.ESSITY
Q3 202418 Jan 2026 - Record sales, profit, and higher dividend in 2024, with focus on growth and innovation for 2025.ESSITY
Q4 202410 Jan 2026